Boundless Bio (BOLD) Interest & Investment Income (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Interest & Investment Income of $920000.0 for Q1 2026, down 41.96% year-over-year from $1.6 million in Q1 2025, and down 17.64% quarter-over-quarter from $1.1 million in Q4 2025.
Boundless Bio (BOLD) Interest & Investment Income (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Interest & Investment Income for 4 consecutive years, with $920000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 41.96% year-over-year to $920000.0; the TTM figure through Mar 2026 stood at $3.3 million (down 41.93% YoY), while the FY2025 annual figure was $5.4 million, down 32.12% from the prior year.
- Interest & Investment Income retreated to $920000.0 in Q1 2026 per BOLD's latest filing, from $1.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.2 million in Q3 2024 and bottomed at -$61000.0 in Q1 2024.
- Historically, Interest & Investment Income has averaged $1.1 million across 4 years, with a median of $1.3 million in 2025.
- Annual changes were most pronounced in 2024 — Interest & Investment Income tumbled 115.44% — and 2025, when it jumped 2698.36%.
- Boundless Bio's Interest & Investment Income stood at $1.6 million in 2023, then gained by 18.21% to $1.9 million in 2024, then tumbled by 41.67% to $1.1 million in 2025, then slipped by 17.64% to $920000.0 in 2026.
- Business Quant data shows BOLD's Interest & Investment Income at $920000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - | 690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 690,000.00 |
| Mar 31, 2026 | 920,000.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | -36,000.00 |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 395,000.00 |